MENU
RETA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Reata Pharmaceuticals (RETA) Ownership - Who owns Reata Pharmaceuticals?

Profile

Industry
Pharmaceuticals Major
Address
5320 Legacy Drive
Phone
+1 972 865-2219
Employees
323
Web
https://www.reatapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.57B
P/E Ratio
N/A
Total Cash
330.21M
Projected Growth
N/A
Total Debt
166M
Revenue
23.48M
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash/Share
8.67
Total Debt/Equity
N/A
Revenue/Share
0.61 USD as % of share price

Fundamentals

RETA
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for treatment of inflammatory diseases and cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
5320 Legacy Drive
Phone
+1 972 865-2219
Employees
323
Web
https://www.reatapharma.com